Scholarlink

Background <p>Immunoglobulin A Nephropathy (IgAN) is the most common primary glomerulonephritis, often leading to end-stage kidney disease in 20–40% of cases. Despite extensive research on urinary and serum metabolomics, salivary metabolomics remains unexplored. This study investigates metabolomic alterations in IgAN using both salivary and urinary analyses and examines potential correlations between these biofluids.</p> Methods <p>Metabolomic profiling was performed using liquid chromatography-high resolution mass spectrometry (LC-HRMS) on saliva and urine samples from 16 IgAN patients and 13 matched controls. Data were processed using TidyMass and MetaboAnalyst, with metabolite annotation via HMDB, MassBank and MoNA. Pathway analysis was conducted using the KEGG database, with statistical significance set at <i>p</i> &lt; 0.05 or FDR &lt; 0.05.</p> Results <p>Salivary analysis identified 42 metabolites, with four significantly altered in IgAN patients. Picric acid, Buphedrone and Deoxyadenosine were elevated, while N-Acetylneuraminic acid was reduced, implicating ABC transporters, purine metabolism and neurotransmitter pathways. Urinary analysis revealed 138 metabolites, with 14 significantly altered, primarily affecting the pentose phosphate pathway. No significant correlation was observed between urinary and salivary metabolomic profiles.</p> Conclusion <p>Though urinary and salivary metabolomes showed distinct alterations, our study only supported N-Acetylneuraminic acid as a potential IgAN biomarker.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Metabolomic profiling in IgA nephropathy: urinary and salivary biomarker insights

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月9日

查看全文
  • İbrahim Eslem Demirbağ,
  • Rümeyza Kazancıoğlu,
  • Şahabettin Selek,
  • Evrim Dalkılıç,
  • Meltem Gürsu,
  • Ömer Celal Elçioğlu,
  • Özge Pasin,
  • Metin Demirel

摘要

Background

Immunoglobulin A Nephropathy (IgAN) is the most common primary glomerulonephritis, often leading to end-stage kidney disease in 20–40% of cases. Despite extensive research on urinary and serum metabolomics, salivary metabolomics remains unexplored. This study investigates metabolomic alterations in IgAN using both salivary and urinary analyses and examines potential correlations between these biofluids.

Methods

Metabolomic profiling was performed using liquid chromatography-high resolution mass spectrometry (LC-HRMS) on saliva and urine samples from 16 IgAN patients and 13 matched controls. Data were processed using TidyMass and MetaboAnalyst, with metabolite annotation via HMDB, MassBank and MoNA. Pathway analysis was conducted using the KEGG database, with statistical significance set at p < 0.05 or FDR < 0.05.

Results

Salivary analysis identified 42 metabolites, with four significantly altered in IgAN patients. Picric acid, Buphedrone and Deoxyadenosine were elevated, while N-Acetylneuraminic acid was reduced, implicating ABC transporters, purine metabolism and neurotransmitter pathways. Urinary analysis revealed 138 metabolites, with 14 significantly altered, primarily affecting the pentose phosphate pathway. No significant correlation was observed between urinary and salivary metabolomic profiles.

Conclusion

Though urinary and salivary metabolomes showed distinct alterations, our study only supported N-Acetylneuraminic acid as a potential IgAN biomarker.